Production (Stage)
Genelux Corporation
GNLX
$2.65
-$0.02-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -95.29% | -96.64% | -99.93% | -99.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -95.29% | -96.64% | -99.93% | -99.93% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -95.29% | -96.64% | -99.93% | -99.93% |
| SG&A Expenses | -1.54% | 9.84% | 30.76% | 29.89% | 54.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.57% | 30.28% | 41.28% | 37.68% | 49.72% |
| Operating Income | -21.61% | -31.16% | -42.90% | -217.36% | -329.51% |
| Income Before Tax | -14.46% | -5.56% | -10.53% | -94.12% | -141.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.46% | -5.56% | -10.53% | -79.66% | -119.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.46% | -5.56% | -10.53% | -79.66% | -119.06% |
| EBIT | -21.61% | -31.16% | -42.90% | -217.36% | -329.51% |
| EBITDA | -22.92% | -32.94% | -45.45% | -234.55% | -364.67% |
| EPS Basic | 10.02% | 21.13% | 29.26% | -60.11% | -43.56% |
| Normalized Basic EPS | 8.52% | 20.10% | 28.45% | -106.68% | -61.56% |
| EPS Diluted | 10.02% | 21.13% | 29.26% | -48.27% | -34.07% |
| Normalized Diluted EPS | 8.52% | 20.10% | 28.45% | -82.38% | -46.24% |
| Average Basic Shares Outstanding | 27.46% | 28.68% | 47.37% | 74.19% | 123.56% |
| Average Diluted Shares Outstanding | 27.46% | 28.68% | 47.37% | 71.58% | 119.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |